Motif Bio Plc
(UNKNOWN : MTFB)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
1.08%177.981.3%$463.11m
CELGCelgene Corporation
0.85%97.331.3%$421.68m
GILDGilead Sciences, Inc.
1.28%67.210.9%$393.48m
BIIBBiogen Inc.
2.12%232.491.3%$354.89m
ILMNIllumina, Inc.
1.39%348.783.5%$271.67m
REGNRegeneron Pharmaceuticals, Inc.
2.34%312.392.6%$234.35m
AAgilent Technologies, Inc.
0.44%70.281.6%$213.02m
VRTXVertex Pharmaceuticals Incorporated
2.19%173.941.9%$198.43m
ARRYArray BioPharma Inc.
56.68%46.368.2%$185.73m
EXASExact Sciences Corporation
0.57%110.4125.3%$183.93m
ALXNAlexion Pharmaceuticals, Inc.
2.38%120.742.0%$176.26m
BMRNBioMarin Pharmaceutical Inc.
3.95%84.034.3%$135.97m
MRTXMirati Therapeutics Inc.
6.53%100.412.5%$114.00m
IONSIonis Pharmaceuticals, Inc.
4.04%64.608.2%$96.86m
INCYIncyte Corporation
4.96%81.572.5%$91.64m

Company Profile

Motif Bio Plc is a clinical stage biopharmaceutical company, which engages in the development and commercialization of pharmaceutical formulations. The company focuses on developing novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant bacteria. It offers Iclaprim, a novel diaminopyrimidine antibiotic that inhibits an essential bacterial enzyme called dihydrofolate reductase. The company was founded by Jonathan E. Gold on November 20, 2014 and is headquartered in Princeton, NJ.